1. A Pilot Study of Extended Adjuvant Therapy with Metronomic Docetaxel for Patients with Operable Triple-Negative Breast Cancer

Volume 21, Issue 3, March 2020, Pages 749-754

Bader A Abdelmaksoud; Abdelmotaleb Mohammed; Mostafa M Toam

• View Article
• PDF 295.77 K

2. Topoisomerase II α Gene alteration in Triple Negative Breast Cancer and Its Predictive Role for Anthracycline-Based Chemotherapy (Egyptian NCI Patients)

Volume 19, Issue 12, December 2018, Pages 3581-3589

Mahitab Ibrahim Eltohamy; Omnia Mohammed Badawy; Naglaa El kinaai; Iman Loay; Hanan Ramadan Nassar; Rasha Mahmoud Allam; Mona Ali Sakr

• View Article
• PDF 2.34 MB

3. Clinicopathology Figures and Long-term Effects of Tamoxifen Plus Radiation on Survival of Women with Invasive Ductal Carcinoma and Triple Negative Breast Cancer

Volume 16, Issue 12, December 2015, Pages 4863-4867

• View Article
• PDF 796.79 K

4. Ultrasonographic Features of Triple-Negative Breast Cancer: a Comparison with Other Breast Cancer Subtypes

Volume 16, Issue 8, August 2015, Pages 3229-3232

• View Article
• PDF 383.84 K

5. Increased Hypermethylation of Glutathione S-Transferase P1, DNA-Binding Protein Inhibitor, Death Associated Protein Kinase and Paired Box Protein-5 Genes in Triple-Negative Breast Cancer Saudi Females

Volume 16, Issue 2, February 2015, Pages 541-549

• View Article
• PDF 631.31 K

6. Elevated Serum Haptoglobin is Associated with Clinical Outcome in Triple-Negative Breast Cancer Patients

Volume 13, Issue 9, September 2012, Pages 4541-4544

• View Article
• PDF 495.46 K